{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T13:45:47Z","timestamp":1767015947008,"version":"3.37.3"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1124\/jpet.119.259010","type":"journal-article","created":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T21:59:16Z","timestamp":1565819956000},"page":"544-554","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Behavioral Effects of Opioid Full and Partial Agonists During Chronic Buprenorphine Treatment"],"prefix":"10.1016","volume":"371","author":[{"given":"Sarah L.","family":"Withey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger D.","family":"Spealman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol A.","family":"Paronis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.119.259010_bib1","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.1016\/j.drugalcdep.2015.07.935","article-title":"Adolescent oxycodone self-administration alters subsequent antinociceptive effect of oxycodone in C57BL\/6J mice in adulthood","volume":"156","author":"Altschuler","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.119.259010_bib2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1037\/1064-1297.12.3.163","article-title":"Discriminative stimulus, reinforcing, physical dependence, and antinociceptive effects of oxycodone in mice, rats, and rhesus monkeys","volume":"12","author":"Beardsley","year":"2004","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1124\/jpet.119.259010_bib3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1124\/mi.6.5.9","article-title":"Measuring the reinforcing strength of abused drugs","volume":"6","author":"Bergman","year":"2006","journal-title":"Mol Interv"},{"key":"10.1124\/jpet.119.259010_bib4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-3565(25)20047-7","article-title":"Buprenorphine: dose-related blockade of opioid challenge effects in opioid dependent humans","volume":"247","author":"Bickel","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.119.259010_bib5","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s002130050068","article-title":"Methoclocinnamox: time course of changes in alfentanil-reinforced responding in rhesus monkeys","volume":"148","author":"Briscoe","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.119.259010_bibib35","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1038\/sj.npp.1301008","article-title":"Unlimited Access to Heroin Self-Administration: Independent Motivational Markers of Opiate Dependence","volume":"31","author":"Chen","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.119.259010_bib6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s002130000623","article-title":"Buprenorphine sublingual tablets: effects on IV heroin self-administration by humans","volume":"154","author":"Comer","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.119.259010_bib7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0160-5402(86)90056-2","article-title":"A tail withdrawal procedure for assessing analgesic activity in rhesus monkeys","volume":"15","author":"Dykstra","year":"1986","journal-title":"J Pharmacol Methods"},{"key":"10.1124\/jpet.119.259010_bib8","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1124\/jpet.103.052795","article-title":"Modification by dopaminergic drugs of choice behavior under concurrent schedules of intravenous saline and food delivery in monkeys","volume":"308","author":"Gasior","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.119.259010_bib9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0022-3565(25)29561-1","article-title":"Comparable behavior maintained under fixed-ratio and second-order schedules of food presentation, cocaine injection or d-amphetamine injection in the squirrel monkey","volume":"186","author":"Goldberg","year":"1973","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.119.259010_bib10","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0022-3565(24)29586-0","article-title":"Comparison of pharmacological activities of buprenorphine and norbuprenorphine: norbuprenorphine is a potent opioid agonist","volume":"297","author":"Huang","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"10.1124\/jpet.119.259010_bibib36","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/adb.12163","article-title":"Abuse potential of intranasal buprenorphine versus buprenorphine\/naloxone in buprenorphine\u2010maintained heroin users","volume":"20","author":"Jones","year":"2015","journal-title":"Addiction Biology"},{"key":"10.1124\/jpet.119.259010_bib11","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0014-2999(00)00039-X","article-title":"Buprenorphine and methoclocinnamox: agonist and antagonist effects on respiratory function in rhesus monkeys","volume":"391","author":"Kishioka","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.119.259010_bib12","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0022-3565(25)12844-9","article-title":"Respiratory effects of opioid full and partial agonists in rhesus monkeys","volume":"277","author":"Liguori","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.119.259010_bib13","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0022-3565(25)33600-1","article-title":"Comparison of buprenorphine and methadone effects on opiate self-administration in primates","volume":"225","author":"Mello","year":"1983","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.119.259010_bib14","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1126\/science.7352279","article-title":"Buprenorphine suppresses heroin use by heroin addicts","volume":"207","author":"Mello","year":"1980","journal-title":"Science"},{"key":"10.1124\/jpet.119.259010_bib15","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0022-3565(24)37431-2","article-title":"The effects of buprenorphine on self-administration of cocaine and heroin \u201cspeedball\u201d combinations and heroin alone by rhesus monkeys","volume":"285","author":"Mello","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.119.259010_bib16","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/00008877-200211000-00005","article-title":"Delta opioid antagonist effects of buprenorphine in rhesus monkeys","volume":"13","author":"Negus","year":"2002","journal-title":"Behav Pharmacol"},{"key":"10.1124\/jpet.119.259010_bib17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0014-2999(88)90149-5","article-title":"Kappa antagonist properties of buprenorphine in the shock titration procedure","volume":"156","author":"Negus","year":"1988","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.119.259010_bib18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jsat.2011.12.009","article-title":"Comparing buprenorphine induction experience with heroin and prescription opioid users","volume":"43","author":"Nielsen","year":"2012","journal-title":"J Subst Abuse Treat"},{"key":"10.1124\/jpet.119.259010_bib19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drugalcdep.2005.01.004","article-title":"The effect of buprenorphine and benzodiazepines on respiration in the rat","volume":"79","author":"Nielsen","year":"2005","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.119.259010_bib20","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1124\/jpet.110.173823","article-title":"Buprenorphine and opioid antagonism, tolerance, and naltrexone-precipitated withdrawal","volume":"336","author":"Paronis","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.119.259010_bib21","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00213-002-1180-5","article-title":"Effects of cocaine under concurrent fixed ratio schedules of food and IV drug availability: a novel choice procedure in monkeys","volume":"163","author":"Paronis","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.119.259010_bib22","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/0091-3057(90)90256-H","article-title":"Butorphanol\u2019s efficacy at mu and kappa opioid receptors: inferences based on the schedule-controlled behavior of nontolerant and morphine-tolerant rats and on the responding of rats under a drug discrimination procedure","volume":"36","author":"Picker","year":"1990","journal-title":"Pharmacol Biochem Behav"},{"issue":"Suppl 3","key":"10.1124\/jpet.119.259010_bib23","first-page":"281S","article-title":"Animal and molecular pharmacology of mixed agonist-antagonist analgesic drugs","volume":"7","author":"Rance","year":"1979","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/jpet.119.259010_bib24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/(SICI)1098-2396(199911)34:2<83::AID-SYN1>3.0.CO;2-S","article-title":"Opioid peptide receptor studies. 12. Buprenorphine is a potent and selective mu\/kappa antagonist in the [35S]-GTP-gamma-S functional binding assay","volume":"34","author":"Romero","year":"1999","journal-title":"Synapse"},{"issue":"3","key":"10.1124\/jpet.119.259010_bibib38","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1001\/jama.2016.9382","article-title":"Effect of Buprenorphine Implants on Illicit Opioid Use Among Abstinent Adults With Opioid Dependence Treated With Sublingual Buprenorphine: A Randomized Clinical Trial","volume":"316","author":"Rosenthal","year":"2016","journal-title":"JAMA"},{"key":"10.1124\/jpet.119.259010_bib25","doi-asserted-by":"crossref","first-page":"679","DOI":"10.36076\/ppj.2009\/12\/679","article-title":"Opioid induced hyperalgesia: clinical implications for the pain practitioner","volume":"12","author":"Silverman","year":"2009","journal-title":"Pain Physician"},{"key":"10.1124\/jpet.119.259010_bib27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1521-0391.2011.00186.x","article-title":"Compliance with buprenorphine medication-assisted treatment and relapse to opioid use","volume":"21","author":"Tkacz","year":"2012","journal-title":"Am J Addict"},{"key":"10.1124\/jpet.119.259010_bib28","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0022-3565(25)39450-4","article-title":"Discriminative-stimulus effects of the low efficacy mu agonist nalbuphine","volume":"267","author":"Walker","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.119.259010_bib29","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0022-3565(25)09651-X","article-title":"Buprenorphine antagonism of mu opioids in the rhesus monkey tail-withdrawal procedure","volume":"273","author":"Walker","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.119.259010_bib30","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1001\/jamapsychiatry.2017.1874","article-title":"Effect of buprenorphine weekly depot (CAM2038) and hydromorphone blockade in individuals with opioid use disorder: a randomized clinical trial","volume":"74","author":"Walsh","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1124\/jpet.119.259010_bib31","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0022-3565(25)10510-7","article-title":"Acute administration of buprenorphine in humans: partial agonist and blockade effects","volume":"274","author":"Walsh","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.119.259010_bib32","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00008877-199603000-00006","article-title":"Effects of buprenorphine on behaviour maintained by heroin and alfentanil in rhesus monkeys","volume":"7","author":"Winger","year":"1996","journal-title":"Behav Pharmacol"},{"key":"10.1124\/jpet.119.259010_bib33","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0022-3565(25)10977-4","article-title":"Effects of buprenorphine and other opioid agonists and antagonists on alfentanil- and cocaine-reinforced responding in rhesus monkeys","volume":"261","author":"Winger","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.119.259010_bib34","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jpain.2018.02.003","article-title":"Concurrent assessment of the antinociceptive and behaviorally disruptive effects of opioids in squirrel monkeys","volume":"19","author":"Withey","year":"2018","journal-title":"J Pain"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524268907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524268907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.119.259010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T13:57:58Z","timestamp":1739973478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524268907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0022356524268907"],"URL":"https:\/\/doi.org\/10.1124\/jpet.119.259010","relation":{},"ISSN":["0022-3565"],"issn-type":[{"type":"print","value":"0022-3565"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Behavioral Effects of Opioid Full and Partial Agonists During Chronic Buprenorphine Treatment","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.119.259010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}